Conference
Potential Utility of Event-Free Survival (EFS) As Surrogate Endpoint for Overall Survival (OS) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) after Autologous Stem Cell Transplantation (ASCT): A Subgroup Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Randomized Phase III Trial
Authors
Li S; Hay AE; Crump M; Anglin P; Baetz T; Meyer R; Keating A; Robinson S; Seftel M; Stelitano C
Volume
130
Publisher
AMER SOC HEMATOLOGY
Publication Date
December 7, 2017
Name of conference
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Conference place
GA, Atlanta
Conference start date
December 9, 2017
Conference end date
December 12, 2017
Conference proceedings
BLOOD
ISSN
0006-4971